-
公开(公告)号:US11980672B2
公开(公告)日:2024-05-14
申请号:US17844877
申请日:2022-06-21
申请人: ModernaTX, Inc.
IPC分类号: A61K48/00 , A61K31/7115 , A61K31/712 , A61K31/7125 , A61P1/16 , A61P31/14 , C12N15/10 , C12N15/67 , C12Q1/68
CPC分类号: A61K48/0058 , A61K31/7115 , A61K31/712 , A61K31/7125 , A61K48/0066 , A61P1/16 , A61P31/14 , C12N15/1086 , C12N15/67 , C12N2840/00
摘要: mRNAs containing an exogenous open reading frame (ORF) flanked by a 5′ untranslated region (UTR) and a 3′ UTR is provided, wherein the 5′ and 3′ UTRs are derived from a naturally abundant mRNA in a tissue. Also provided are methods for identifying the 5′ and 3′ UTRs, and methods for making and using the mRNAs.
-
公开(公告)号:US20230050143A1
公开(公告)日:2023-02-16
申请号:US17844877
申请日:2022-06-21
申请人: ModernaTX, Inc.
IPC分类号: A61K48/00 , C12N15/10 , C12N15/67 , A61P1/16 , A61P31/14 , A61K31/7115 , A61K31/712 , A61K31/7125
摘要: mRNAs containing an exogenous open reading frame (ORF) flanked by a 5′ untranslated region (UTR) and a 3′ UTR is provided, wherein the 5′ and 3′ UTRs are derived from a naturally abundant mRNA in a tissue. Also provided are methods for identifying the 5′ and 3′ UTRs, and methods for making and using the mRNAs.
-
3.
公开(公告)号:US20190307857A1
公开(公告)日:2019-10-10
申请号:US15781881
申请日:2016-12-09
申请人: ModernaTX, Inc.
IPC分类号: A61K38/45 , A61K31/7115 , C12N15/52 , A61P3/00 , A61K31/7105
摘要: The invention relates to methods and compositions for treating a UDP glucuronosyltransferase family 1 deficiency based on mRNA therapy.
-
公开(公告)号:US20180353618A1
公开(公告)日:2018-12-13
申请号:US15781827
申请日:2016-12-09
申请人: ModernaTX, Inc.
IPC分类号: A61K48/00 , C12N15/10 , C12N15/67 , A61K31/7115 , A61K31/712 , A61K31/7125 , A61P1/16 , A61P31/14
CPC分类号: A61K48/0058 , A61K31/7115 , A61K31/712 , A61K31/7125 , A61K48/0066 , A61P1/16 , A61P31/14 , C12N15/1086 , C12N15/67 , C12N2840/00
摘要: mRNAs containing an exogenous open reading frame (ORF) flanked by a 5′ untranslated region (UTR) and a 3′ UTR is provided, wherein the 5′ and 3′ UTRs are derived from a naturally abundant mRNA in a tissue. Also provided are methods for identifying the 5′ and 3′ UTRs, and methods for making and using the mRNAs.
-
-
-